Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp

Bullboard Posts

Comment by Yowza123on Sep 24, 2020 8:56am

143 Views

Post# 31610266

RE:RE:RE:RE:Lexaria gets P.O. for 4.4M servings with 56M to come

I suppose that would make sense if licensing fees were averaged in. In the 9mo leading up to that only 48% of revenue was from product sales and 52% was from licensing fees. If the licensing fees are already paid by the client then that wouldn't that make the unit cost worth about twice as much?

Bullboard Posts

Cross border trading in Canada and Australia